Prot #MVT-601-3002: LIBERTY 2: An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Co-Administered with and without Low-Dose Estradiol and Norethindrone Acetate in Women with Heavy Menstrua

Project: Research project

Project Details

StatusFinished
Effective start/end date9/19/179/19/20

Funding

  • LBR Regulatory and Clinical Consulting Services, Inc. (Prot #MVT-601-3002)
  • Myovant Sciences, Inc. (Prot #MVT-601-3002)